Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwok-Kin Wong

Showing results (1-10 of 360) with videos related to

Pageof 36
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
HKI-272 in non small cell lung cancerKwok-Kin Wong
Lung Cancer (Amsterdam, Netherlands)|June 3, 2008
Searching for a magic bullet in NSCLC: the role of epidermal growth factor receptor mutations and tyrosine kinase inhibitorsKwok-Kin Wong
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Mouse models of lung cancerAmit Dutt, Kwok-Kin Wong
Journal of the National Cancer Institute|August 21, 2003
Walking the telomere plank into cancerKwok-Kin Wong, Ronald A DePinho
The Journal of Clinical Investigation|April 12, 2003
The age of cancer: telomeres, checkpoints, and longevityRonald A DePinho, Kwok-Kin Wong
Cancer Discovery|April 3, 2019
EZH2 Inhibitors: Take It EZy, It Is All About ContextVamsidhar Velcheti, Kwok-Kin Wong, Yogen Saunthararajah
Cancer Prevention Research (Philadelphia, Pa.)|April 1, 2010
NF-kappaB fans the flames of lung carcinogenesisKwok-Kin Wong, Tyler Jacks, Glenn Dranoff
Cell Cycle (Georgetown, Tex.)|September 14, 2006
EGFR targeted therapy: view from biological standpointHongbin Ji, Norman E Sharpless, Kwok-Kin Wong
Current Opinion in Genetics & Development|December 17, 2009
Targeting the PI3K signaling pathway in cancerKwok-Kin Wong, Jeffrey A Engelman, Lewis C Cantley
Frontiers in Oncology|May 1, 2013
Activating Mutations in ERBB2 and Their Impact on Diagnostics and TreatmentGrit S Herter-Sprie, Heidi Greulich, Kwok-Kin Wong
Pageof 36

Showing results (1-10 of 360) with videos related to

Sort By:
Pageof 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
HKI-272 in non small cell lung cancerKwok-Kin Wong
Lung Cancer (Amsterdam, Netherlands)|June 3, 2008
Searching for a magic bullet in NSCLC: the role of epidermal growth factor receptor mutations and tyrosine kinase inhibitorsKwok-Kin Wong
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Mouse models of lung cancerAmit Dutt, Kwok-Kin Wong
Journal of the National Cancer Institute|August 21, 2003
Walking the telomere plank into cancerKwok-Kin Wong, Ronald A DePinho
The Journal of Clinical Investigation|April 12, 2003
The age of cancer: telomeres, checkpoints, and longevityRonald A DePinho, Kwok-Kin Wong
Cancer Discovery|April 3, 2019
EZH2 Inhibitors: Take It EZy, It Is All About ContextVamsidhar Velcheti, Kwok-Kin Wong, Yogen Saunthararajah
Cancer Prevention Research (Philadelphia, Pa.)|April 1, 2010
NF-kappaB fans the flames of lung carcinogenesisKwok-Kin Wong, Tyler Jacks, Glenn Dranoff
Cell Cycle (Georgetown, Tex.)|September 14, 2006
EGFR targeted therapy: view from biological standpointHongbin Ji, Norman E Sharpless, Kwok-Kin Wong
Current Opinion in Genetics & Development|December 17, 2009
Targeting the PI3K signaling pathway in cancerKwok-Kin Wong, Jeffrey A Engelman, Lewis C Cantley
Frontiers in Oncology|May 1, 2013
Activating Mutations in ERBB2 and Their Impact on Diagnostics and TreatmentGrit S Herter-Sprie, Heidi Greulich, Kwok-Kin Wong
Pageof 36